POINT BIOPHARMA

point-biopharma-logo

POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer. POINT Biopharma Global Inc. is combining a portfolio of best-in-class radiopharmaceutical assets, a seasoned management team, expertise in radioisotopes such as Actinium-225 (Ac-225) and Lutetium-177 (Lu-177), manufacturing technology and novel direct-to-patient targeting to revolutionize theragnostic drug development and radioligand commercialization.

#SimilarOrganizations #People #Financial #Event #Website #More

POINT BIOPHARMA

Social Links:

Industry:
Biopharma Biotechnology Health Care Therapeutics

Founded:
2017-01-01

Address:
Indianapolis, Indiana, United States

Country:
United States

Website Url:
http://www.pointbiopharma.com

Total Employee:
11+

Status:
Active

Contact:
(317) 543-9957

Total Funding:
165 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network


Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

otonomy-logo

Otonomy

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

regenxcel-logo

Regenxcel

A CDMO to enable the development and commercialization of cell-based therapies for regenerative medicine technologies.

Current Employees Featured

robin-hallett_image

Robin Hallett
Robin Hallett Vice President, Discovery & Translational Sciences @ Point Biopharma
Vice President, Discovery & Translational Sciences
2021-12-01

not_available_image

Sherin Al-Safadi
Sherin Al-Safadi VP Medical Affairs @ Point Biopharma
VP Medical Affairs
2021-12-01

bill-demers_image

Bill Demers
Bill Demers Chief Financial Officer @ Point Biopharma
Chief Financial Officer

chris-horvath_image

Chris Horvath
Chris Horvath EVP, Commercial @ Point Biopharma
EVP, Commercial
2022-06-01

dr-neil-fleshner_image

Dr. Neil Fleshner
Dr. Neil Fleshner Chief Medical Officer @ Point Biopharma
Chief Medical Officer

justyna-kelly_image

Justyna Kelly
Justyna Kelly Chief Operating Officer @ Point Biopharma
Chief Operating Officer
2021-12-01

joe-mccann_image

Joe McCann
Joe McCann Founder, Chief Executive Officer @ Point Biopharma
Founder, Chief Executive Officer

Founder


howard-glase_image

Howard Glase

joe-mccann_image

Joe McCann

Stock Details


Company's stock symbol is NASDAQ:PNT

Investors List

farallon-capital-management_image

Farallon Capital Management

Farallon Capital Management investment in Post-IPO Equity - Point Biopharma

sphera-global-health-care-fund_image

Sphera Global Healthcare Fund

Sphera Global Healthcare Fund investment in Post-IPO Equity - Point Biopharma

woodline-partners_image

Woodline Partners

Woodline Partners investment in Post-IPO Equity - Point Biopharma

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Post-IPO Equity - Point Biopharma

suvretta-capital-management_image

Suvretta Capital Management

Suvretta Capital Management investment in Post-IPO Equity - Point Biopharma

bvf-partners_image

BVF Partners

BVF Partners investment in Post-IPO Equity - Point Biopharma

boxer-capital_image

Boxer Capital

Boxer Capital investment in Post-IPO Equity - Point Biopharma

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Post-IPO Equity - Point Biopharma

johnson-johnson-innovation-jjdc_image

Johnson & Johnson Innovation – JJDC

Johnson & Johnson Innovation – JJDC investment in Post-IPO Equity - Point Biopharma

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Post-IPO Equity - Point Biopharma

Official Site Inspections

http://www.pointbiopharma.com Semrush global rank: 2.43 M Semrush visits lastest month: 7.44 K

  • Host name: ec2-18-188-128-145.us-east-2.compute.amazonaws.com
  • IP address: 18.188.128.145
  • Location: Columbus United States
  • Latitude: 39.9653
  • Longitude: -83.0235
  • Metro Code: 535
  • Timezone: America/New_York
  • Postal: 43215

Loading ...

More informations about "Point Biopharma" on Search Engine